KISSEI PHARMACEUTICAL CO., LTD.
4547・Prime Market・Pharmaceuticals
KISSEI PHARMACEUTICAL CO., LTD.4547
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-11-11 | Other | イセルティの台湾における子宮内膜症の追加適応症取得について |
| 2026-11-11 | Other | Yselty Receives Additional Indication for Endometriosis in Taiwan |
| 2026-11-09 | Other | 半期報告書-第82期(2026/04/01-2027/03/31) |
| 2026-11-05 | Other | Notice Concerning the Results of the Acquisition of Treasury Shares through ToSTNeT-3 |
| 2026-11-05 | Other | Financial Briefing for the Second Quarter (Interim) of the Fiscal Year Ended March 31, 2027 (Fiscal 2026) |
| 2026-11-05 | Other | 自己株式立会外買付取引(ToSTNeT-3)による自己株式の取得結果に関するお知らせ |
| 2026-11-05 | Other | 2027年3月期 第2四半期(中間期)決算説明会資料 |
| 2026-11-04 | Other | 自己株式の取得状況に関するお知らせ |
| 2026-11-04 | Other | Supplementary Explanatory Materials on Financial Results for the Six Months Ended September 30, 2026 |
| 2026-11-04 | Other | Notice Concerning the Purchase of Treasury Shares through ToSTNeT-3 |

